Corindus Vascular Robotics, Inc. CVRS Income Statement

Corindus vascular robotics, inc. (CVRS)

Income statement / TTM

Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11
Revenue
-	-	-	-	-	-	-	-	-	-	2,842	3,136	2,660	3,061	2,729	2,519	2,861	3,029	2,983	2,388	1,843	0	-	0	0	-	-	-	-	-	-	-	-
Revenue
15,242	12,332	10,781	10,298	9,765	10,358	9,650	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	175	162	162	171	151	0	0	0
Cost of revenue
9,785	9,158	8,673	8,904	9,253	9,302	9,265	7,905	6,942	5,856	5,042	4,672	4,174	4,001	3,724	3,257	0	0	-	0	-	57	120	177	198	212	187	164	162	123	0	0	0
Cost of revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-	-	-	-	-	-
Gross profit (loss)
5,457	3,174	2,108	1,394	512	1,056	385	-1,907	-2,681	-3,345	-2,200	-1,536	-1,514	-940	-995	-1,615	-1,344	-1,293	-1,921	-874	-923	-962	-310	-316	-36	-36	0	0	0	-	-	-	-
Operating expenses:
Research and development
11,229	9,510	8,769	8,141	8,599	9,088	9,517	10,486	10,721	10,567	10,313	9,555	9,090	9,580	10,033	9,602	8,691	7,324	6,607	6,381	0	0	-	0	-	-	-	-	-	-	-	-	-
Selling, general and administrative
28,491	26,992	27,300	27,908	27,128	26,160	24,777	23,143	22,140	20,671	19,564	18,247	17,547	17,124	16,143	15,431	15,342	14,176	13,002	0	0	0	-	-	-	-	-	-	-	-	-	-	-
Compensation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10	10	10	10	10	10	10	10	9	0	0	0
Consulting fees - related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	-	-	-	-
General and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	73	778	785	147	91	85	87	92	70	0	0	0
Sales and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-
Restructuring charge
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	175	175	0	0	-	0	-	-	-	-	-	-	-	-	-
Total operating expense
39,717	36,848	36,415	36,398	36,076	35,248	34,294	33,629	32,861	31,238	29,877	27,802	26,637	26,704	26,176	25,033	24,033	21,582	19,784	14,531	12,896	8,589	3,714	3,685	206	150	150	192	222	202	0	0	0
Operating loss
-34,260	-33,674	-34,307	-35,004	-35,564	-34,192	-33,909	-35,536	-35,542	-34,583	-32,077	-29,338	-28,151	-27,644	-27,171	-26,648	-25,377	-22,875	-21,705	-15,405	-13,819	-9,552	-4,025	-4,002	-242	-186	-132	-112	-93	-51	0	0	0
Other income (expense)
Interest expense
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17	15	12	3	3	0	0	0	0	0	0	0
Interest income
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant revaluation
-	-	120	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest, net
-	-1,110	-	-553	-	-118	-208	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other, net
-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Warrant revaluation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,421	0	0	-	0	-	-	-	-	-	-	-	-	-
Other, net
-991	-942	-682	-274	28	-96	-214	-407	-614	-753	-1,001	-1,178	-1,361	-1,577	-1,592	-1,411	-1,046	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-	-
Total other income (expense), net
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-1,434	-4,092	-5,001	-2,836	-2,625	0	0	-	0	-	-	-	-	-	-	-	-	-
Other (income) expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	3	0	0	0	-	-	-	-
Loss before income tax provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-267	-291	-265	-245	-189	-133	-113	-93	-51	0	0	0
Income tax provision
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	0	0	0	0	0	0
Net loss
-35,368	-34,616	-34,989	-35,525	-35,783	-34,288	-34,123	-35,943	-36,156	-35,336	-33,078	-30,516	-29,512	-29,221	-28,763	-28,082	-29,469	-27,876	-24,541	-18,044	-13,386	-7,778	-4,022	-3,996	-245	-189	-133	-113	-93	-51	0	0	0
Accretion of beneficial conversion feature of Series A and Series A-1 preferred stock
0	-	5,206	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends on preferred stock
1,504	1,506	884	0	0	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of Series A-1 preferred stock as dividends on Series A preferred stock
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-38,916	-37,656	-42,643	-42,397	-41,897	-39,649	-34,123	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common stockholders--basic and diluted (in dollars per share)
-	-0.05	-	-0.04	-	-0.08	-0.05	-0.04	-0.04	-0.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)
-	196,691	-	189,377	-	188,771	189,330	187,301	187,190	131,880	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributed to common stockholders--basic and diluted (in dollars per share)
-0.06	-	-	-	-0.06	-	-	-	-	-	-0.09	-0.07	-0.06	-0.06	-0.05	-0.06	-0.07	-0.07	-0.06	-0.10	-0.08	-0.05	0.00	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Weighted-average common shares used in computing net loss per share attributable to common stockholders--basic and diluted (in shares)
207,121	-	-	-	188,833	-	-	-	-	-	119,024	118,958	119,049	119,046	118,819	118,541	109,775	105,883	106,262	86,977	73,360	73,360	-	73,360	52,000	-	-	-	-	-	-	-	-
Net loss
-35,368	-34,616	-34,989	-35,525	-35,783	-34,288	-34,123	-35,943	-36,156	-35,336	-33,078	-30,516	-29,512	-29,221	-28,763	-28,082	-29,469	-27,876	-24,541	-18,044	-13,386	-7,778	-4,022	-3,996	-245	-189	-133	-113	-93	-51	0	0	0
Unrealized gain (loss) on marketable securities
-	-	-	-	-	-	-	-	-	-	14	7	16	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Comprehensive loss
-35,368	-34,616	-34,989	-35,525	-35,783	-34,288	-34,123	-35,943	-36,165	-35,340	-33,064	-30,509	-29,503	-29,217	-28,777	-29,990	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding - basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52,000	-	-	-	52,000	52,000	52,000	65,592	52,000	31,267	0